Logo image of CRLA.PA

CRCAM DU LANGUEDOC (CRLA.PA) Stock Analyst Earnings Estimates

EPA:CRLA - Euronext Paris - Matif - FR0010461053 - Common Stock - Currency: EUR

61.5  -0.79 (-1.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
CRLA.PA revenue by date.CRLA.PA revenue by date.
704.3M
20.37%
758.786M
7.74%
730.365M
-3.75%
EBITDA
YoY % growth
CRLA.PA ebitda by date.CRLA.PA ebitda by date.
N/AN/AN/A
EBIT
YoY % growth
CRLA.PA ebit by date.CRLA.PA ebit by date.
N/AN/AN/A
Operating Margin
CRLA.PA operating margin by date.CRLA.PA operating margin by date.
N/AN/AN/A
EPS
YoY % growth
CRLA.PA eps by date.CRLA.PA eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
CRLA.PA Yearly EPS VS EstimatesCRLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
395.199M
2.54%
%
Q4 2023
Q2Q % growth
345.172M
2.15%
%
Q2 2023
Q2Q % growth
385.396M
-8.63%
%
Q4 2022
Q2Q % growth
337.91M
-3.24%
%
Q2 2022
Q2Q % growth
421.805M
18.80%
%
Q4 2021
Q2Q % growth
349.227M
14.75%
%
Q2 2021
Q2Q % growth
355.053M
24.73%
%
Q4 2020
Q2Q % growth
304.35M
0.17%
%
Q2 2020
Q2Q % growth
284.66M
-16.99%
%
CRLA.PA Yearly Revenue VS EstimatesCRLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A